A whole‐genome massively parallel sequencing analysis of <b><i>BRCA1</i></b> mutant oestrogen receptor‐negative and ‐positive breast cancers

Rachael Natrajan(Institute of Cancer Research), Jorge S. Reis‐Filho(AstraZeneca (France)), Petra van der Groep(Amsterdam UMC Location Vrije Universiteit Amsterdam), Adriana C. Flora(Institute of Cancer Research), Olivier Delattre(Institut Curie), William D. Foulkes(McGill University Health Centre), Patty T. Wai(Institute of Cancer Research), Marc‐Henri Stern(Université Paris Sciences et Lettres), Iwanka Kozarewa(AstraZeneca (United Kingdom)), Anne Vincent‐Salomon(Université Paris Sciences et Lettres), Roger A’Hern, Britta Weigelt(Memorial Sloan Kettering Cancer Center), Samra Turajlic(Royal Marsden NHS Foundation Trust), Anita Grigoriadis(London Cancer), Simon J. Furney(King's College London), Richard Marais(Macclesfield College), Odette Mariani(Institut Curie), Simon S. McDade(Queen's University Belfast), Élodie Manié(Inserm), Alan Mackay(Institute of Cancer Research), Ian O. Ellis(University of Nottingham), Paul van Diest(University Medical Center Utrecht), Jason S. Carroll(Cancer Research UK Cambridge Center), Christopher J. Lord(Institute of Cancer Research), Daniel‐Nava Rodruigues(Institute of Cancer Research), Andrew R. Green(Nottingham Biomedical Research Centre), Tatiana Popova(Institut Curie), Alan Ashworth(University of California, San Francisco), Dominique Stoppa‐Lyonnet(Inserm), Maryou B. Lambros(Institute of Cancer Research), Vidya Pawar(Institute of Cancer Research), Paul M Wilkerson(University Hospitals Bristol NHS Foundation Trust), Charles Swanton(The Francis Crick Institute)
The Journal of Pathology
February 23, 2012
Cited by 65


Related Papers